CTMX — CYTOMX THERAPEUTICS INC.
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 184 家机构在其最新 13F 申报中持有 CTMX(CYTOMX THERAPEUTICS INC.),合计申报市值 $784.53M,对应 209.33M 股。按股数计算较上季度增持 14.9%(+26.12M 股),申报市值环比下降 8.3%。持仓集中度较高:前五大持有人占申报市值的 46.6%,前十大的集中度为 61.7%。
与上一季度相比,51 家新建仓位、68 家加仓、36 家减仓、47 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
CYTOMX THERAPEUTICS INC.(CTMX)的主要机构持有人包括 Fidelity Management & Research (FMR)、Kynam Capital Management, LP、Bank of America Corp,按 13F 申报市值在本页 330 家持有人中排名居前。
CTMX 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 126 | 110.65M | $301.00M | +14.5% |
| Q2 2026 | 184 | 209.33M | $784.53M | +14.9% |
| Q1 2026 | 180 | 192.17M | $903.19M | +48.9% |
| Q4 2025 | 125 | 134.80M | $574.26M | +14.4% |
| Q3 2025 | 108 | 133.35M | $425.35M | +3.6% |
| Q2 2025 | 88 | 131.95M | $299.43M | +75.5% |
| Q1 2025 | 67 | 44.86M | $28.55M | -7.0% |
| Q4 2024 | 70 | 46.41M | $47.79M | +3.1% |
表内 8 个季度中,机构持股合计增加 138%(Q4 2024 → Q3 2026);单季变动最大的是 Q2 2025(+75.5%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 34.34M | $93.39M | 0.00% | 增持 | |
| 18.47M | $50.24M | 0.00% | 增持 | |
| 9.03M | $24.55M | 0.00% | 增持 | |
| 8.73M | $23.75M | 0.00% | 增持 | |
| 5.09M | $13.86M | 0.00% | 增持 | |
| 4.36M | $11.87M | 0.02% | 增持 | |
| 4.19M | $11.39M | 0.02% | 增持 | |
| 3.46M | $9.40M | 0.22% | 持有 | |
| 3.44M | $9.35M | 0.00% | 减持 | |
| 2.06M | $5.59M | 0.00% | 增持 | |
| 1.48M | $4.03M | 0.01% | 增持 | |
| 1.39M | $3.79M | 0.00% | 增持 | |
| 1.18M | $3.21M | 0.00% | 增持 | |
| 825.28K | $2.24M | 0.00% | 增持 | |
| 737.87K | $2.01M | 0.02% | 增持 | |
| 706.96K | $1.92M | 0.00% | 增持 | |
| 684.18K | $1.86M | 0.00% | 增持 | |
| 639.54K | $1.74M | 0.00% | 减持 | |
| 568.00K | $1.54M | 0.00% | 增持 | |
| 477.55K | $1.30M | 0.54% | 持有 | |
| 467.92K | $1.27M | 0.00% | 增持 | |
| 467.64K | $1.27M | 0.00% | 减持 | |
| 462.06K | $1.26M | 0.54% | 新进 | |
| 446.91K | $1.22M | 0.00% | 新进 | |
| 439.47K | $1.20M | 0.00% | 减持 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 32.71M | $122.68M | 0.01% | 增持 | |
| 21.70M | $81.39M | 4.50% | 增持 | |
| 17.56M | $65.85M | 0.00% | 增持 | |
| 15.08M | $56.56M | 0.00% | 增持 | |
| 10.44M | $39.15M | 0.62% | 增持 | |
| 8.53M | $31.97M | 0.00% | 减持 | |
| 7.81M | $29.29M | 0.11% | 减持 | |
| 5.17M | $19.38M | 0.00% | 增持 | |
| 5.17M | $19.38M | 0.00% | 增持 | |
| 4.98M | $18.68M | 0.57% | 减持 | |
| 4.98M | $18.66M | 0.10% | 持有 | |
| 4.68M | $17.55M | 0.00% | 新进 | |
| 4.68M | $17.55M | 0.00% | 增持 | |
| 4.55M | $17.06M | 4.29% | 持有 | |
| 4.45M | $16.69M | 0.79% | 持有 | |
| 4.13M | $15.50M | 0.02% | 增持 | |
| 3.56M | $13.34M | 0.70% | 增持 | |
| 3.47M | $13.01M | 0.01% | 增持 | |
| 3.46M | $12.97M | 0.26% | 持有 | |
| 3.37M | $12.62M | 0.70% | 减持 | |
| 3.02M | $11.34M | 0.02% | 减持 | |
| 2.04M | $7.65M | 0.02% | 增持 | |
| 2.00M | $7.51M | 0.00% | 增持 | |
| 1.86M | $6.98M | 0.00% | 减持 | |
| 1.82M | $6.84M | 0.01% | 减持 |
Q1 2026 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 31.96M | $150.19M | 0.01% | 增持 | |
| 15.01M | $70.56M | 4.55% | 增持 | |
| 10.20M | $47.95M | 0.00% | 增持 | |
| 10.10M | $47.46M | 1.00% | 增持 | |
| 9.98M | $46.92M | 1.75% | 减持 | |
| 8.73M | $41.05M | 0.00% | 新进 | |
| 7.88M | $37.01M | 0.15% | 增持 | |
| 5.66M | $26.62M | 0.00% | 增持 | |
| 5.23M | $24.57M | 0.00% | 增持 | |
| 4.98M | $23.39M | 0.14% | 增持 | |
| 4.55M | $21.39M | 6.07% | 增持 | |
| 4.45M | $20.91M | 1.47% | 新进 | |
| 4.14M | $19.45M | 0.03% | 增持 | |
| 3.66M | $17.20M | 0.01% | 增持 | |
| 3.66M | $17.20M | 0.02% | 增持 | |
| 3.58M | $16.84M | 0.00% | 新进 | |
| 3.58M | $16.84M | 0.00% | 新进 | |
| 3.46M | $16.25M | 0.45% | 新进 | |
| 3.41M | $16.03M | 1.11% | 增持 | |
| 3.19M | $14.99M | 0.80% | 增持 | |
| 3.12M | $14.66M | 0.01% | 增持 | |
| 3.07M | $14.42M | 0.26% | 增持 | |
| 2.71M | $12.74M | 0.02% | 增持 | |
| 2.25M | $10.57M | 0.03% | 增持 | |
| 2.07M | $9.72M | 0.00% | 增持 |
Q4 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 24.69M | $105.17M | 0.01% | 增持 | |
| 15.56M | $66.29M | 3.27% | 持有 | |
| 9.68M | $41.24M | 0.78% | 持有 | |
| 8.97M | $38.20M | 2.55% | 增持 | |
| 8.48M | $36.11M | 0.00% | 减持 | |
| 7.69M | $32.77M | 2.18% | 持有 | |
| 5.19M | $22.11M | 0.08% | 增持 | |
| 5.14M | $21.90M | 0.00% | 增持 | |
| 4.25M | $18.11M | 0.11% | 持有 | |
| 3.83M | $16.31M | 0.03% | 增持 | |
| 3.67M | $15.63M | 0.00% | 增持 | |
| 3.53M | $15.02M | 0.32% | 减持 | |
| 3.17M | $13.52M | 1.56% | 减持 | |
| 2.88M | $12.29M | 0.79% | 持有 | |
| 2.51M | $10.68M | 0.54% | 新进 | |
| 2.46M | $10.48M | 0.00% | 增持 | |
| 2.34M | $9.96M | 0.04% | 持有 | |
| 1.56M | $6.65M | 0.01% | 增持 | |
| 1.53M | $6.50M | 0.00% | 减持 | |
| 1.29M | $5.49M | 0.00% | 增持 | |
| 1.16M | $4.93M | 0.01% | 增持 | |
| 1.06M | $4.52M | 0.01% | 增持 | |
| 1.04M | $4.41M | 0.86% | 新进 | |
| 900.00K | $3.83M | 0.01% | 持有 | |
| 894.66K | $3.81M | 0.10% | 减持 |
Q3 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 15.56M | $49.64M | 2.79% | 增持 | |
| 15.40M | $49.11M | 0.00% | 增持 | |
| 11.07M | $35.30M | 1.36% | 持有 | |
| 9.68M | $30.88M | 0.93% | 增持 | |
| 8.95M | $28.54M | 0.00% | 减持 | |
| 8.46M | $26.99M | 0.69% | 持有 | |
| 7.69M | $24.54M | 1.20% | 持有 | |
| 4.25M | $13.56M | 0.10% | 增持 | |
| 4.07M | $12.98M | 0.05% | 减持 | |
| 4.05M | $12.90M | 1.32% | 增持 | |
| 3.65M | $11.63M | 0.87% | 增持 | |
| 3.46M | $11.04M | 0.14% | 持有 | |
| 3.37M | $10.76M | 1.73% | 新进 | |
| 2.88M | $9.20M | 0.74% | 减持 | |
| 2.66M | $8.49M | 0.10% | 持有 | |
| 2.55M | $8.12M | 0.01% | 增持 | |
| 2.38M | $7.60M | 0.00% | 持有 | |
| 2.34M | $7.46M | 0.04% | 持有 | |
| 1.57M | $5.01M | 0.00% | 减持 | |
| 1.39M | $4.42M | 0.01% | 增持 | |
| 1.39M | $4.42M | 0.00% | 增持 | |
| 1.38M | $4.41M | 0.01% | 新进 | |
| 1.24M | $3.95M | 0.10% | 新进 | |
| 1.10M | $3.52M | 0.01% | 减持 | |
| 1.01M | $3.21M | 0.00% | 增持 |
Q2 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 13.97M | $31.71M | 2.38% | 新进 | |
| 11.07M | $25.12M | 1.27% | 增持 | |
| 9.38M | $21.29M | 0.00% | 增持 | |
| 9.24M | $20.97M | 0.00% | 增持 | |
| 8.46M | $19.21M | 0.50% | 新进 | |
| 8.08M | $18.35M | 0.09% | 增持 | |
| 7.69M | $17.46M | 1.23% | 新进 | |
| 6.99M | $15.88M | 0.59% | 新进 | |
| 5.77M | $13.10M | 0.00% | 新进 | |
| 5.77M | $13.10M | 1.34% | 新进 | |
| 3.90M | $8.85M | 1.15% | 新进 | |
| 3.52M | $7.98M | 1.95% | 减持 | |
| 3.48M | $7.91M | 0.08% | 新进 | |
| 3.46M | $7.86M | 0.11% | 新进 | |
| 3.08M | $6.99M | 1.17% | 增持 | |
| 2.87M | $6.50M | 0.02% | 新进 | |
| 2.66M | $6.04M | 0.10% | 增持 | |
| 2.39M | $5.42M | 0.00% | 增持 | |
| 2.35M | $5.34M | 0.01% | 增持 | |
| 2.34M | $5.30M | 0.03% | 增持 | |
| 2.15M | $4.89M | 0.53% | 新进 | |
| 1.86M | $4.23M | 0.01% | 增持 | |
| 1.75M | $3.96M | 0.00% | 增持 | |
| 1.30M | $2.96M | 0.20% | 新进 | |
| 844.64K | $1.92M | 0.09% | 新进 |
新建仓(Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 4.68M 股 · $17.55M
- DV EQUITIES, LLC 714.00K 股 · $2.68M
- Sixth Street Partners Management Company, L.P. 549.88K 股 · $2.06M
- Nuveen, LLC 448.04K 股 · $1.68M
- RHUMBLINE ADVISERS 222.51K 股 · $834.42K
- Focus Partners Wealth 197.88K 股 · $742.04K
- PRICE T ROWE ASSOCIATES INC /MD/ 148.11K 股 · $556.00K
- ALLIANCEBERNSTEIN L.P. 104.31K 股 · $490.26K
- Walleye Capital LLC 126.53K 股 · $474.47K
- MetLife Investment Management, LLC 104.64K 股 · $392.38K
- Robertson Stephens Wealth Management, LLC 96.00K 股 · $360.00K
- ALGERT GLOBAL LLC 90.90K 股 · $340.88K
完全清仓(较上季)
- STATE STREET CORP 卖出 5.66M 股 · $26.62M
- Jefferies Financial Group Inc. 卖出 3.07M 股 · $14.42M
- Patient Square Capital LP 卖出 1.09M 股 · $5.10M
- EVENTIDE ASSET MANAGEMENT, LLC 卖出 900.00K 股 · $4.23M
- Trexquant Investment LP 卖出 898.77K 股 · $4.22M
- Balyasny Asset Management 卖出 730.84K 股 · $3.43M
- DV Trading LLC 卖出 714.00K 股 · $3.36M
- Informed Momentum Co LLC 卖出 565.11K 股 · $2.66M
- Longaeva Partners L.P. 卖出 550.00K 股 · $2.58M
- SEVEN GRAND MANAGERS, LLC 卖出 325.00K 股 · $1.53M
- DIADEMA PARTNERS LP 卖出 316.00K 股 · $1.49M
- Soleus Capital Management, L.P. 卖出 300.00K 股 · $1.41M
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) | 34.34M | 32.71M | 31.96M | 24.69M | 15.40M | 9.24M | 108.31K | 306.78K | 284.31K | 242.36K | 183.08K | 565.32K | 707.97K | 727.38K | 705.70K | 716.65K | 701.57K | 703.21K | 701.82K | 536.43K |
| BlackRock Inc | 18.47M | 17.56M | 5.23M | 3.67M | 2.38M | 2.39M | 1.17M | 1.24M | 1.17M | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 9.03M | — | 5.66M | 5.14M | 644.98K | 639.04K | 320.04K | 320.04K | 263.64K | 263.64K | 267.48K | 267.48K | 267.48K | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 8.73M | 8.53M | 8.73M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 5.09M | 4.68M | 2.07M | 1.53M | 1.57M | 1.75M | 857.96K | 815.64K | 803.53K | 769.50K | 753.40K | 702.65K | 676.34K | 644.09K | 642.31K | 603.08K | 587.45K | 583.07K | 1.05M | 1.17M |
| Marshall Wace | 4.36M | 3.02M | 4.14M | 1.16M | 1.10M | 2.35M | 85.54K | — | — | — | 52.29K | 363.28K | 377.59K | 674.50K | 729.94K | — | 40.02K | 64.14K | 15.27K | — |
| Qube Research & Technologies Ltd | 4.19M | 1.82M | 2.25M | 1.06M | 122.50K | — | 54.81K | 55.11K | 55.11K | 54.61K | 133.20K | 259 | 259 | — | — | — | — | — | — | — |
| Siren, L.L.C. | 3.46M | 3.46M | 3.46M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 3.44M | 3.47M | 3.12M | 370.74K | 30.17K | 408.04K | 746.79K | 508.56K | 69.14K | 70.37K | 20.49K | 20.05K | 18.70K | 21.44K | 26.79K | 45.80K | 17.79K | 4.21K | 1.71K | 140.48K |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.06M | 1.75M | 794.75K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Squarepoint Ops LLC | 1.48M | 112.15K | 241.22K | 49.90K | 47.73K | 49.39K | — | — | 109.00K | 198.84K | 47.00K | 150.53K | 173.62K | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 1.39M | 1.27M | 1.10M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Assenagon Asset Management S.A. | 1.18M | 364.17K | 364.17K | 592.70K | 729.97K | 720.02K | 711.45K | 599.85K | 1.64M | 1.24M | 404.67K | 404.67K | 425.92K | — | — | — | — | — | — | — |
| BNP PARIBAS FINANCIAL MARKETS | 825.28K | 31.71K | 606.27K | 2.83K | 17 | 17 | 17 | 78 | 194 | 78 | 78 | 78 | 236 | — | — | — | — | — | — | — |
| Jump Financial, LLC | 737.87K | 347.40K | 10.72K | — | — | — | — | — | — | — | 38.58K | — | — | — | — | — | — | — | — | — |
| BNY Mellon | 706.96K | 684.54K | 289.87K | 328.25K | 252.66K | 252.66K | 241.98K | 241.98K | 241.98K | 241.98K | 241.98K | 266.84K | 266.84K | 31.87K | 36.15K | 36.15K | 36.19K | 36.19K | 212.29K | 213.09K |
| Deutsche Bank AG | 684.18K | 663.04K | 463.42K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 38.15K | 42.32K |
| DIMENSIONAL FUND ADVISORS LP | 639.54K | 1.86M | 1.93M | 1.29M | 451.13K | 183.17K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BARCLAYS PLC | 568.00K | 126.42K | 142.41K | 336.52K | 1.49K | 2 | 2 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| SCHULHOFF & CO INC | 477.55K | 477.55K | 477.55K | 374.85K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold CTMX?
As of 2026-Q2, 184 institutional funds reported holding CTMX (CYTOMX THERAPEUTICS INC.) in SEC 13F filings, with a combined reported value of $784.53M.
How many shares of CTMX do institutions own?
13F filers reported 209.33M shares of CTMX, worth $784.53M in aggregate at the end of 2026-Q2.
Is institutional ownership of CTMX rising or falling?
Share counts moved +14.9% versus the prior quarter — accumulation.
Who are the top institutional holders of CTMX?
The largest 13F holders are Fidelity Management & Research (FMR), Kynam Capital Management, LP, Bank of America Corp, BlackRock Inc, PERCEPTIVE ADVISORS LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of CYTOMX THERAPEUTICS INC.?
The major shareholders of CYTOMX THERAPEUTICS INC. (CTMX) by reported 13F value are Fidelity Management & Research (FMR), Kynam Capital Management, LP, Bank of America Corp, BlackRock Inc, PERCEPTIVE ADVISORS LLC, among 330 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.